- Home
- NRSN vs EKSO Comparison
NRSN vs EKSO Comparison
Compare NRSN & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- EKSO
- Stock Information
- Founded
- NRSN 2017
- EKSO 2005
- Country
- NRSN Israel
- EKSO United States
- Employees
- NRSN N/A
- EKSO N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- EKSO Medical/Dental Instruments
- Sector
- NRSN Health Care
- EKSO Health Care
- Exchange
- NRSN Nasdaq
- EKSO Nasdaq
- Market Cap
- NRSN 24.7M
- EKSO 22.0M
- IPO Year
- NRSN 2021
- EKSO N/A
- Fundamental
- Price
- NRSN $1.10
- EKSO $1.03
- Analyst Decision
- NRSN
- EKSO Strong Buy
- Analyst Count
- NRSN 0
- EKSO 2
- Target Price
- NRSN N/A
- EKSO $6.25
- AVG Volume (30 Days)
- NRSN 150.1K
- EKSO 45.4K
- Earning Date
- NRSN 11-26-2024
- EKSO 10-24-2024
- Dividend Yield
- NRSN N/A
- EKSO N/A
- EPS Growth
- NRSN N/A
- EKSO N/A
- EPS
- NRSN N/A
- EKSO N/A
- Revenue
- NRSN N/A
- EKSO $18,160,000.00
- Revenue This Year
- NRSN N/A
- EKSO $13.35
- Revenue Next Year
- NRSN N/A
- EKSO $36.81
- P/E Ratio
- NRSN N/A
- EKSO N/A
- Revenue Growth
- NRSN N/A
- EKSO 15.63
- 52 Week Low
- NRSN $0.40
- EKSO $0.75
- 52 Week High
- NRSN $2.33
- EKSO $3.13
- Technical
- Relative Strength Index (RSI)
- NRSN 46.61
- EKSO 41.43
- Support Level
- NRSN $0.92
- EKSO $1.00
- Resistance Level
- NRSN $1.22
- EKSO $1.10
- Average True Range (ATR)
- NRSN 0.11
- EKSO 0.07
- MACD
- NRSN -0.04
- EKSO -0.00
- Stochastic Oscillator
- NRSN 40.00
- EKSO 16.67
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.